Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-03-01 @ 12:05 PM
Study NCT ID:
NCT00550004
Status:
TERMINATED
Last Update Posted:
2011-06-08
First Post:
2007-10-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
Sponsor:
SciClone Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SCI-RP-Pan-P2-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Israel Rios, M.D
Old Organization:
Sciclone Pharmaceuticals, Inc.